Beatriz Martin-Antonio - Fundacion Jimenez Diaz

基本信息

Career Trajectory

Bio

Beatriz Martin-Antonio currently works at the Department of Experimental Hematology, Fundacion Jimenez Diaz (Madrid). Beatriz does research in NK and CAR-T cellular immunotherapy for treating hematological malignancies. My current project is the study of mechanisms associated with senescence and immunosenescence to improve the persistence of CAR-T cells in patients.

Research Interests

Papers共 145 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

ARI0003: Co-transduced CD19/BCMA Dual-Targeting CAR-T Cells for the Treatment of Non-Hodgkin Lymphoma

Mireia Bachiller, Nina Barcelo-Genestar,Alba Rodriguez-Garcia,Leticia Alserawan,Celia Dobano-Lopez,Marta Gimenez-Alejandre,Joan Castellsague, Salut Colell, Marc Otero-Mateo,Asier Antonana-Vildosola,Marta Espanol-Rego, Noelia Ferruz,Mariona Pascal,Beatriz Martin-Antonio, Xavier M. Anguela,Cristina Fillat,Eulalia Olesti,Gonzalo Calvo,Manel Juan,Julio Delgado,Patricia Perez-Galan, Alvaro Urbano-Ispizua,Sonia Guedan

MOLECULAR THERAPYno. 1 (2025): 317-335

Cited1Views0WOSBibtex

Bicistronic CAR-T Cell Against BCMA and CD229 Effectively Controls Myeloma Even when BCMA Expression is Limited

Luis Gerardo Rodríguez-Lobato, Oriol Cardus, Joan Mañé Pujol,Anthony M Battram, Sergi Vaqué-Salsench, Judith Carpio, Lorena Pérez-Amill, Hugo Calderón,Beatriz Martin-Antonio,Aina Oliver-Caldés,Ester Lozano, David F Moreno,Valentin Ortiz-Maldonado,Maria Queralt Salas, Anna de Daniel,Natalia Tovar, M Teresa Cibeira,Laura Rosinol,Joan Bladé,Manel Juan, Álvaro Urbano-Ispizua,Pablo Engel,Carlos Fernández de Larrea

Cancer immunology research (2025)

Cited0Views0WOSBibtex

Supplementary Figure S14 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

openalex（2024）

Cited0Views0Bibtex

Supplementary Figure S2 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

crossref（2024）

Cited0Views0Bibtex

Supplementary Table S4 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure S12 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

openalex（2024）

Cited0Views0Bibtex

Supplementary Table S9 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure S1 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

openalex（2024）

Cited0Views0Bibtex

Supplementary Data S1 from Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma

openalex（2024）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn